Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.88% | 3.75% | 25.43% | -34.97% | -2.48% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | 199.95% |
| Total Other Non-Cash Items | -21.43% | -96.96% | 12,200.00% | -9.09% | 109.59% |
| Change in Net Operating Assets | 1,588.07% | 98.31% | -1,792.76% | -79.60% | 2,040.10% |
| Cash from Operations | 0.63% | 22.39% | 5.00% | -127.06% | 37.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -142.43% | -- | -100.00% |
| Total Debt Repaid | 67.23% | -- | 100.00% | -2,155.64% | 32.00% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 39.02% | 45.43% | -101.36% | 9,434.21% | -102.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.36% | 156.84% | -131.86% | 751.56% | -156.62% |